Madrigal Pharmaceuticals, Inc. (MDGL) - Latest Market Data

Price & Market Data

Price: $435.0

Daily Change: -$1.86 / 0.43%

Daily Range: $424.7 - $448.2

Market Cap: $9,879,695,360

Daily Volume: 468,892

Performance Metrics

1 Week: -8.19%

1 Month: -12.47%

3 Months: -22.18%

6 Months: 11.07%

1 Year: 23.92%

YTD: -25.30%

Company Details

Employees: 915

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.

Selected stocks

Anika Therapeutics Inc. (ANIK)

Natera, Inc. (NTRA)

Nutriband Inc. (NTRB)